IL140667A0 - Compositions containing at least one active substance having an influence on the levels of lipids in the blood - Google Patents
Compositions containing at least one active substance having an influence on the levels of lipids in the bloodInfo
- Publication number
- IL140667A0 IL140667A0 IL14066799A IL14066799A IL140667A0 IL 140667 A0 IL140667 A0 IL 140667A0 IL 14066799 A IL14066799 A IL 14066799A IL 14066799 A IL14066799 A IL 14066799A IL 140667 A0 IL140667 A0 IL 140667A0
- Authority
- IL
- Israel
- Prior art keywords
- lipids
- blood
- levels
- influence
- active substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19830732A DE19830732B4 (en) | 1998-07-09 | 1998-07-09 | Composition containing at least one substance influencing blood lipid levels and its use |
| PCT/EP1999/004757 WO2000002541A1 (en) | 1998-07-09 | 1999-07-07 | Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL140667A0 true IL140667A0 (en) | 2002-02-10 |
Family
ID=7873488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14066799A IL140667A0 (en) | 1998-07-09 | 1999-07-07 | Compositions containing at least one active substance having an influence on the levels of lipids in the blood |
| IL140667A IL140667A (en) | 1998-07-09 | 2001-01-01 | Compositions containing at least one active substance having an influence on the levels of lipids in the blood |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL140667A IL140667A (en) | 1998-07-09 | 2001-01-01 | Compositions containing at least one active substance having an influence on the levels of lipids in the blood |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1094797B1 (en) |
| JP (1) | JP2002520272A (en) |
| KR (1) | KR100549848B1 (en) |
| CN (1) | CN1309377C (en) |
| AR (1) | AR019902A1 (en) |
| AT (1) | ATE278395T1 (en) |
| AU (1) | AU770573B2 (en) |
| BR (1) | BR9911941A (en) |
| CA (1) | CA2336712C (en) |
| CZ (1) | CZ300976B6 (en) |
| DE (2) | DE19830732B4 (en) |
| ES (1) | ES2230872T3 (en) |
| HU (1) | HU226614B1 (en) |
| IL (2) | IL140667A0 (en) |
| MX (1) | MXPA01000126A (en) |
| NZ (1) | NZ509215A (en) |
| PL (1) | PL194983B1 (en) |
| RU (1) | RU2227023C2 (en) |
| TR (1) | TR200100021T2 (en) |
| TW (1) | TWI237572B (en) |
| WO (1) | WO2000002541A1 (en) |
| ZA (1) | ZA200100171B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL189890B1 (en) * | 1999-09-14 | 2005-10-31 | Kazmierski Jan Zaklad Prod Usl | Preparation for protecting plants against diseases |
| WO2004026297A1 (en) * | 2002-09-20 | 2004-04-01 | Kowa Co., Ltd. | Preparation for external use |
| US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| AU2004203700B2 (en) * | 2003-01-02 | 2007-06-21 | Femmepharma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| WO2005094814A1 (en) * | 2004-03-31 | 2005-10-13 | Kowa Co., Ltd. | External preparation |
| JP4986411B2 (en) * | 2004-06-01 | 2012-07-25 | 久光製薬株式会社 | Patch |
| US8173155B2 (en) | 2004-06-01 | 2012-05-08 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
| US20050281868A1 (en) * | 2004-06-21 | 2005-12-22 | Fairfield Clinical Trials, Llc | Transdermal delivery system for statin combination therapy |
| DE102004062182B4 (en) * | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient |
| CA2644851A1 (en) * | 2006-03-07 | 2007-09-13 | Osteoscreen Ip, Llc | Hmg co-a reductase inhibitor enhancement of bone and cartilage |
| KR100817274B1 (en) * | 2006-08-21 | 2008-03-27 | 삼성전기주식회사 | Light emitting diode package and method of manufacturing the same |
| WO2018115535A1 (en) | 2016-12-19 | 2018-06-28 | Nutritape, S.L. | Energising patch for sportspeople |
| CN113573794B (en) * | 2019-03-12 | 2023-06-16 | 康宁股份有限公司 | Ceramic honeycomb body with skin |
| TWI803052B (en) * | 2021-11-12 | 2023-05-21 | 佛教慈濟醫療財團法人 | Transdermal delivery device, methods of using and making the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3634016A1 (en) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | AREA-BASED THERAPEUTIC SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND ITS USE |
| US5503844A (en) * | 1993-05-18 | 1996-04-02 | Mli Acquisition Corp. Ii | Foam laminate transdermal patch |
| FR2719220A1 (en) * | 1994-04-29 | 1995-11-03 | Lafon Labor | New galenic form for transdermal administration. |
| DE69524614T2 (en) * | 1994-10-05 | 2002-09-12 | Hisamitsu Pharmaceutical Co., Inc. | MEDICINAL COMPONENTS, INCLUDING AN N-SUBSTITUTED O-TOLUIDE INDEXIVATIVE AND TRANSDERMALLY ABSORBABLE PREPARATION |
| DE19541260A1 (en) * | 1995-11-06 | 1997-05-07 | Lohmann Therapie Syst Lts | Therapeutic preparation for transdermal application of active ingredients through the skin |
| WO1999024032A1 (en) * | 1997-11-10 | 1999-05-20 | Novo Nordisk A/S | Transdermal delivery of 3,4-diarylchromans |
-
1998
- 1998-07-09 DE DE19830732A patent/DE19830732B4/en not_active Expired - Lifetime
-
1999
- 1999-07-06 TW TW088111470A patent/TWI237572B/en not_active IP Right Cessation
- 1999-07-07 TR TR2001/00021T patent/TR200100021T2/en unknown
- 1999-07-07 ES ES99936490T patent/ES2230872T3/en not_active Expired - Lifetime
- 1999-07-07 AU AU51574/99A patent/AU770573B2/en not_active Expired
- 1999-07-07 EP EP99936490A patent/EP1094797B1/en not_active Expired - Lifetime
- 1999-07-07 AR ARP990103304A patent/AR019902A1/en active IP Right Grant
- 1999-07-07 CA CA002336712A patent/CA2336712C/en not_active Expired - Lifetime
- 1999-07-07 NZ NZ509215A patent/NZ509215A/en not_active IP Right Cessation
- 1999-07-07 KR KR1020017000286A patent/KR100549848B1/en not_active IP Right Cessation
- 1999-07-07 CZ CZ20010093A patent/CZ300976B6/en unknown
- 1999-07-07 RU RU2001102046/15A patent/RU2227023C2/en active
- 1999-07-07 WO PCT/EP1999/004757 patent/WO2000002541A1/en active IP Right Grant
- 1999-07-07 DE DE59910758T patent/DE59910758D1/en not_active Expired - Lifetime
- 1999-07-07 PL PL345510A patent/PL194983B1/en unknown
- 1999-07-07 MX MXPA01000126A patent/MXPA01000126A/en active IP Right Grant
- 1999-07-07 BR BR9911941-2A patent/BR9911941A/en not_active Application Discontinuation
- 1999-07-07 IL IL14066799A patent/IL140667A0/en active IP Right Grant
- 1999-07-07 JP JP2000558801A patent/JP2002520272A/en active Pending
- 1999-07-07 HU HU0102718A patent/HU226614B1/en unknown
- 1999-07-07 CN CNB998084255A patent/CN1309377C/en not_active Expired - Lifetime
- 1999-07-07 AT AT99936490T patent/ATE278395T1/en not_active IP Right Cessation
-
2001
- 2001-01-01 IL IL140667A patent/IL140667A/en not_active IP Right Cessation
- 2001-01-08 ZA ZA200100171A patent/ZA200100171B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL140667A (en) | 2007-05-15 |
| EP1094797A1 (en) | 2001-05-02 |
| RU2227023C2 (en) | 2004-04-20 |
| CA2336712C (en) | 2008-09-09 |
| ES2230872T3 (en) | 2005-05-01 |
| DE19830732B4 (en) | 2008-11-13 |
| PL194983B1 (en) | 2007-07-31 |
| NZ509215A (en) | 2003-04-29 |
| TR200100021T2 (en) | 2001-05-21 |
| AR019902A1 (en) | 2002-03-20 |
| BR9911941A (en) | 2001-03-27 |
| TWI237572B (en) | 2005-08-11 |
| ATE278395T1 (en) | 2004-10-15 |
| EP1094797B1 (en) | 2004-10-06 |
| JP2002520272A (en) | 2002-07-09 |
| MXPA01000126A (en) | 2002-06-04 |
| WO2000002541A1 (en) | 2000-01-20 |
| CN1309377C (en) | 2007-04-11 |
| PL345510A1 (en) | 2001-12-17 |
| AU770573B2 (en) | 2004-02-26 |
| CN1308525A (en) | 2001-08-15 |
| HU226614B1 (en) | 2009-04-28 |
| HUP0102718A3 (en) | 2002-12-28 |
| HUP0102718A2 (en) | 2002-03-28 |
| DE19830732A1 (en) | 2000-01-13 |
| DE59910758D1 (en) | 2004-11-11 |
| CZ200193A3 (en) | 2001-05-16 |
| KR100549848B1 (en) | 2006-02-06 |
| KR20010079513A (en) | 2001-08-22 |
| CA2336712A1 (en) | 2000-01-20 |
| ZA200100171B (en) | 2001-08-10 |
| CZ300976B6 (en) | 2009-09-30 |
| AU5157499A (en) | 2000-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0981649A4 (en) | Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same | |
| HUP0400887A3 (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same | |
| HUP0105089A3 (en) | Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles | |
| IL140862A (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the same | |
| FI973828A (en) | Compounds and compositions for administering the active ingredients | |
| HUP0103707A3 (en) | Formulation of stable oxalyplatinum solution | |
| PL347310A1 (en) | Combination of two or more active ingredients using microencapsulated formulations | |
| ZA992549B (en) | Incorporation of active substances in carrier matrixes. | |
| HUP0103925A3 (en) | Storable active substance concentrate containing formoterol | |
| IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| SI1419789T1 (en) | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these | |
| IL138725A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
| IL140667A0 (en) | Compositions containing at least one active substance having an influence on the levels of lipids in the blood | |
| GB9827964D0 (en) | Active backplane circuitry | |
| HU9802795D0 (en) | Pharmaceutical compositions containing more active components | |
| IL143802A0 (en) | Imidazole derivatives and pharmaceutical compositions containing the same | |
| GB2323037B (en) | Evaluating the fit of an orthopaedic implant | |
| NZ318391A (en) | Fungicidal compositions comprising fenazaquine as an active substance | |
| DE69919490D1 (en) | POWDER WITH FAT-SOLUBLE ACTIVE SUBSTANCE | |
| IL127439A0 (en) | Precipitated silicas which contain an active substance | |
| IL136612A0 (en) | Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same | |
| SG68529A1 (en) | The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent | |
| IL142534A0 (en) | Pharmaceutical compositions containing an antigen-adjuvent | |
| HK1043125A1 (en) | Sulphonyloxazolamines as therapeutic active ingredients | |
| IL138994A0 (en) | 2-methylpropionic acid derivatives and medicinal compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |